EL
58
-9
UA
39
-14
XEL
57
-8
ECL
62
-2
PEP
29
-3
AMAT
61
-3
MPC
62
2
UNP
46
-7
KSS
64
-7
PSX
67
7
FOX
73
-2
HAL
64
-4
WMT
58
-4
LB
11
-3
URI
62
-3
SLB
59
-3
ROP
35
2
M
53
-3
DLTR
74
-4
INTC
68
6
EL
58
-9
UA
39
-14
XEL
57
-8
ECL
62
-2
PEP
29
-3
AMAT
61
-3
MPC
62
2
UNP
46
-7
KSS
64
-7
PSX
67
7
FOX
73
-2
HAL
64
-4
WMT
58
-4
LB
11
-3
URI
62
-3
SLB
59
-3
ROP
35
2
M
53
-3
DLTR
74
-4
INTC
68
6
Financhill
Back

ProShares VIX Short-Term Futures ETF Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Sell
21

VIXY
ProShares VIX Short-Term Futures ETF

Last Price:
$25.40
Seasonality Move:
3.79%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$53.22
Seasonality Move:
-13.28%
Sell
21
ProShares VIX Short-Term Futures ETF (VIXY) is a Sell

Is ProShares VIX Short-Term Futures ETF a Buy, Sell or Hold?

  • The current ProShares VIX Short-Term Futures ETF [VIXY] share price is $25.68. The Score for VIXY is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • VIXY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VIXY Stock Price Chart

What is ProShares VIX Short-Term Futures ETF's stock price today?

  • The ProShares VIX Short-Term Futures ETF share price today is $25.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VIXY is experiencing selling pressure, which indicates risk of future bearish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

VIXY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.63 Sell
Relative Strength Index (14 RSI): 32.77 Sell
Chaikin Money Flow: 1626404 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

VIXY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.73 Sell
20-day SMA: 27.32 Sell
50-day SMA: 30.69 Sell
200-day SMA: 42.36 Sell
8-day EMA: 25.88 Sell
20-day EMA: 27.31 Sell
50-day EMA: 29.93 Sell
200-day EMA: 38.56 Sell

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

ProShares VIX Short-Term Futures ETF Earnings Growth & VIXY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

ProShares VIX Short-Term Futures ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):